CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Hand-foot-syndrome is associated with improved survival in patients treated with sorafenib for hepatocellular carcinoma
DOI 10.1055/s-0034-1397172
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Pfeiffenberger, D Gotthardt, D Unger, B Radeleff, C Springfeld, P Schirmacher, P Schemmer, W Stremmel, KH Weiss
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Hepatocellular carcinoma (HCC) is a frequent complication of chronic liver diseases and a leading cause of cancer related deaths. Systemic treatments for HCC like sorafenib might be limited by toxicity and impaired liver function. Clear parameters predicting to the response to sorafenib therapy are sparse. Patients and methods: Single center cohort study of patients suffering from advanced HCC treated…
Zitieren
Zitierempfehlung
J Pfeiffenberger, D Gotthardt, D Unger, B Radeleff, C Springfeld, P Schirmacher, P Schemmer, W Stremmel, KH Weiss (2015) Hand-foot-syndrome is associated with improved survival in patients treated with sorafenib for hepatocellular carcinoma. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0034-1397172
Mit CareLit weiterarbeiten